Biolegend, 368520, Alexa Fluor® 594 anti-human CD45 Antibody
100microg
Catalog Number: 368520
Send an RFQ.
Category
Loading…
| Verified Reactivity | Human |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Immunogen | Human PBMC |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 594 under optimal conditions. |
| Concentration | 0.5 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | IHC-P - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a concentration range of 2.5 - 10 μg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 594 has an excitation maximum of 590 nm, and a maximum emission of 617 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
| Application Notes | It was found that the HI30 clone and the 2D1 clone can cross block each other's binding. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application References(PubMed link indicates BioLegend citation) | Bradstock KF, et al. 1980. J. Natl. Cancer Inst. 65:33. Csiba A, et al. 1984. Br. J. Cancer 50:699. Tchilian EZ, et al. 2001. J. Immunol. 166:1308. Lee MS, et al. 2004. Int. Immunol. 16:1109. |
|---|
| Product Citations | Ishibashi R, et al. 2019. Oncol Lett. 5.192361111. PubMed Si L, et al. 2021. Nat Biomed Eng. 5:815. PubMed |
|---|
| RRID | AB_2629598 (BioLegend Cat. No. 368520) |
|---|
| Structure | Type I transmembrane protein, 180 - 240 kD (multiple isoforms) |
|---|
| Distribution | Hematopoietic cells, except circulating erythrocytes or platelets. |
|---|
| Function | Tyrosine phosphatases, signaling, co-stimulation (co-inhibition), TCR and BCR mediated activation. |
|---|
| Ligand/Receptor | Galectin-1, CD2, CD3, and CD4. |
|---|
| Cell Type | B cells, Dendritic cells, Neutrophils |
|---|
| Biology Area | Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers |
|---|
| Molecular Family | CD Molecules, Protein Kinases/Phosphatase, TCRs |
|---|
| Antigen References | 1. Thomas M. 1989. Annu. Rev. Immunol. 7:339. 2. Trowbridge I, et al. 1994. Annu. Rev. Immunol. 12:85. |
|---|
| Gene ID | 5788 |
|---|
| UniProt | View information about CD45 on UniProt.org |
|---|
| Clone | 2D1 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Leukocyte Common Antigen (LCA), T200 |
|---|
| Isotype | Mouse IgG1, κ |
|---|
